Discriminative value of serum amyloid A and other acute-phase proteins for coronary heart disease.
about
Advances in the Study of the Antiatherogenic Function and Novel Therapies for HDLInfluence of apoA-I and apoE on the formation of serum amyloid A-containing lipoproteins in vivo and in vitroRole of haptoglobin in polycystic ovary syndrome (PCOS), obesity and disorders of glucose tolerance in premenopausal women.A role for the high-density lipoprotein receptor SR-B1 in synovial inflammation via serum amyloid-A.Sustained low-grade pro-inflammatory state in unmedicated, remitted women with major depressive disorder as evidenced by elevated serum levels of the acute phase proteins C-reactive protein and serum amyloid AComparison of serum amyloid A protein and C-reactive protein levels as inflammatory markers in periodontitis.Pathophysiologic mechanisms of cardiovascular disease in obstructive sleep apnea syndromeAdvances in the management of hyperlipidemia-induced atherosclerosis.Proteomic analysis of plasma-purified VLDL, LDL, and HDL fractions from atherosclerotic patients undergoing carotid endarterectomy: identification of serum amyloid A as a potential marker.The correlation between the cardio-ankle vascular index (CAVI) and serum amyloid A in asymptomatic Japanese subjects.Urea-induced denaturation of apolipoprotein serum amyloid A reveals marginal stability of hexamer.Endothelial injury markers before and after nasal continuous positive airway pressure treatment for obstructive sleep apnoea hypopnoea syndrome.Effect of diet-induced energy deficit and body fat reduction on high-sensitive CRP and other inflammatory markers in obese subjects.
P2860
Q26801507-DA55734C-44DB-4FE8-BDDD-6FC7669D810FQ28593885-C6142382-0F93-4183-B8A8-060D074C9951Q33445558-30BF2B42-0308-48D4-87C4-D901219CC9B4Q33745289-1C447A00-9204-4DAC-8CC5-C2A62A5E51F5Q34592629-B16AFFEC-737D-4899-9B3E-23B823791556Q35123578-A2C03436-46DC-4218-BD4B-E6DCFCBEC754Q37015491-3BEBDB38-045E-4A80-81E1-3D3F40F145A1Q37104870-26AFA64E-AB12-4644-84DA-77DAE76E1C52Q37456214-8D95BD4F-A8AE-4FAF-857E-CC6EC835866EQ39710689-E3518946-DCA4-4681-BD13-1CE36396898DQ43057974-AB1106EE-DC36-43A1-A788-AA824DC7B604Q48137999-33131100-0579-499D-8D9C-4FF53BCAE0FAQ51803362-7F9F8856-070A-47BF-B5ED-A18C57EF1878
P2860
Discriminative value of serum amyloid A and other acute-phase proteins for coronary heart disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2002
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Discriminative value of serum ...... ns for coronary heart disease.
@en
Discriminative value of serum ...... ns for coronary heart disease.
@nl
type
label
Discriminative value of serum ...... ns for coronary heart disease.
@en
Discriminative value of serum ...... ns for coronary heart disease.
@nl
prefLabel
Discriminative value of serum ...... ns for coronary heart disease.
@en
Discriminative value of serum ...... ns for coronary heart disease.
@nl
P2093
P1433
P1476
Discriminative value of serum ...... ns for coronary heart disease.
@en
P2093
Dirk De Bacquer
Joris R Delanghe
Lieve Van Renterghem
Michel R Langlois
Paul Capel
Rudolf Mak
P304
P356
10.1016/S0021-9150(01)00607-4
P577
2002-02-01T00:00:00Z